CHAMPIONS ONCOLOGY, INC.

Champions Oncology (CSBR) shows zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, indicating no acute governance or disclosure crises in the recent period. However, low signal in a three-month window does not establish low structural risk; the company's capital structure, equity dilution history, and financing trajectory require deeper analysis. The full $49 Report extends coverage to 12 months of SEC filings, calculates dilution risk scores, maps 8-K context and patterns, and flags AI-detected signals in cash burn and financing dependency. The full $49 Report adds dilution quantification, 12-month filing context, and forward-looking capital risk signals.